 |
|
What relates to the short-term effectiveness of biliary drainage?
November 18, 2009Biliary drainage is performed as a palliative treatment of hilar cholangiocarcinoma. The reduction of serum bilirubin is usually the hallmark of successful biliary drainage. However, some patients may have persistent jaundice or scanty bile output after biliary drainage.
A research team, led by Dr. Chiung-Yu Chen from National Cheng Kung University retrospectively analyzed the clinical and imaging characteristics of these patients in an attempt to identify the factors related to bile output and reduction of serum bilirubin after percutaneous transhepatic biliary drainage (PTBD).
Their was published on November 7, 2009 in the World Journal of Gastroenterology.
The results showed patients with more bile duct visualized on percutaneous transhepatic cholangiography or absence of multiple liver metastases on imaging studies had more bile output after biliary drainage [odds ratio (OR): 8.471, P = 0.010 and OR: 1.959, P = 0.022, respectively]. Patients with prolonged prothrombin time had a slow decrease in serum bilirubin (OR: 0.437, P = 0.005). The median survival time was not significantly different in patients with low or high bile output (75 d vs 125 d, P = 0.573) or in patients with slow or rapid reduction of serum bilirubin (88 d vs 94 d, P = 0.576).
The authors suggested the effectiveness of percutaneous biliary drainage can be properly estimated before the procedure. Patient should be observed for daily bile output as well as the reduction of serum bilirubin. An initially well functioning biliary drainage does not link to a longer survival of patients and further efforts to maintain biliary patency are required.
World Journal of Gastroenterology
The results showed patients with more bile duct visualized on percutaneous transhepatic cholangiography or absence of multiple liver metastases on imaging studies had more bile output after biliary drainage [odds ratio (OR): 8.471, P = 0.010 and OR: 1.959, P = 0.022, respectively]. Patients with prolonged prothrombin time had a slow decrease in serum bilirubin (OR: 0.437, P = 0.005). The median survival time was not significantly different in patients with low or high bile output (75 d vs 125 d, P = 0.573) or in patients with slow or rapid reduction of serum bilirubin (88 d vs 94 d, P = 0.576).
The authors suggested the effectiveness of percutaneous biliary drainage can be properly estimated before the procedure. Patient should be observed for daily bile output as well as the reduction of serum bilirubin. An initially well functioning biliary drainage does not link to a longer survival of patients and further efforts to maintain biliary patency are required.
World Journal of Gastroenterology
Mayo Clinic finds new pathology tests double sensitivity to detect bile duct and pancreatic cancers
Pancreatic cancer and bile duct cancer are difficult to diagnose and often fatal because they are discovered in the advanced stages of the disease.
How about the feasibility of endoscopic ultrasonography-guided choledochoduodenostomy?
Endoscopic ultrasonography (EUS)-guided biliary drainage for treatment of patients who have obstructive jaundice in cases of failed endoscopic retrograde cholangiopancreatography (ERCP).
More Biliary Drainage Current Events and Biliary Drainage News Articles
|
Nonsurgical Biliary Drainage by M. Classen (Contributor) | |
|
Endoscopic Biliary and Pancreatic Drainage by Kornelis Huibregtse (Author) | |
|
Personal experiences with non-surgical biliary drainage by Julius Friedenwald (Author) | |
|
Non-surgical drainage of the gall tract: A treatise concerned with the diagnosis and treatment of certain diseases of the biliary and allied systems, in ... and general cliniacl medicine by Bethuel B. Vincent Lyon (Author) |
| © 2010 BrightSurf.com |